Poor Graft Function
📧 Sign up to get email alerts when something new happens for Poor Graft Function.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function [Phase 2]
This clinical trial update describes a Phase 2 study evaluating infusion of mesenchymal stem cells as treatment for steroid-resistant acute …
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: Study of Efficacy and Safety of Eltrombopag in Patients With Poor Graft Function [Phase 2]
Phase 2 trial update on eltrombopag for poor graft function has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Decitabine for Poor Graft Function Post Allo-HSCT [Phase 3]
A Phase 3 clinical trial evaluating decitabine for poor graft function after allogeneic hematopoietic stem cell transplantation.
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCT [Phase 3]
Phase 3 clinical trial evaluating decitabine with umbilical cord blood for poor graft function after allogeneic hematopoietic stem cell tran…
-
CLINICAL_TRIALS trial_result · 2018-02-19Clinical Trial Update: Eltrombopag For Secondary Poor Graft Function Post Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial update evaluating eltrombopag for secondary poor graft function after allogeneic hematopoietic stem cell transplantat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-09-16Clinical Trial Update: MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment [Phase 2, Phase 3]
This ClinicalTrials.gov entry describes a Phase 2/Phase 3 trial evaluating mesenchymal stem cells with or without peripheral blood stem cell…
-
CLINICAL_TRIALS research · 2013-01-16Clinical Trial Update: Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating mesenchymal stem cells for treating poor graft function after an allogeneic hematopoietic stem cell transp…